Product Information

ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.3075 per EA under NDC 51672404601. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Sep 18, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET

Enalapril Maleate and Hydrochlorothiazide
$0.3075per EA

Strength

10; 25 mg/1; mg/1

NDC

51672404601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA075788

FDA Approved

9/18/2001

TE Code

AB

On Market Since

9/18/2001

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 248.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3075 per EA
All-time high$0.3075 (Nov 18, 2026)
All-time low$0.0852 (Jul 23, 2014)
52-week high$0.3075
52-week low$0.1540
Median price$0.1628
Average price$0.1674
Largest weekly change+82.1% (Dec 19, 2018)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+25.7%

1M

+47.4%

3M

+72.1%

6M

+67.5%

1Y

+73.3%

3Y

+115.2%

5Y

+33.8%

All

+248.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Enalapril Maleate and Hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.3075 per EA (NDC 51672404601), effective Nov 18, 2026.

How has the price of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has risen 248.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?

Since Nov 28, 2013, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has ranged from a low of $0.0852 (Jul 23, 2014) to a high of $0.3075 (Nov 18, 2026), with a median of $0.1628 per EA.

Are there cheaper alternatives to ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?

ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET (NDC 51672404601) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.